Eulav Asset Management’s West Pharmaceutical Svsc Inc Position
Does Eulav Asset Management own West Pharmaceutical Svsc Inc (WST)? Not currently — the last reported position was 104.6K shares worth $29M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$29M
Q4 2025
Shares
104.6K
% of Portfolio
+0.77%
Quarters Held
12
position exited
Position History WST
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 104.6K | $29M | +0.77% |
| Q3 2025 | 104.6K | $27M | +0.64% |
| Q2 2025 | 137.6K | $30M | +0.71% |
| Q1 2025 | 137.6K | $31M | +0.76% |
| Q4 2024 | 137.6K | $45M | +1.09% |
| Q3 2024 | 137.6K | $41M | +1.01% |
| Q2 2024 | 137.6K | $45M | +1.23% |
| Q1 2024 | 128.6K | $51M | +1.40% |
| Q4 2023 | 128.6K | $45M | +1.40% |
| Q3 2023 | 114.0K | $43M | +1.56% |
| Q2 2023 | 68.5K | $26M | +0.98% |
| Q1 2023 | 11.1K | $4M | +0.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eulav Asset Management’s full portfolio or all institutional holders of WST.